CEP162 p.Met77Thr
c.230T>C · VCV4225982
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0879 | likely benign |
|---|---|---|
| REVEL | 0.069 | moderately benign-leaning |
| SaProt | LLR -4.70 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.47 | GERP -3.5 |
| Regional constraint | o/e 1.01 | unconstrained · MANE · 101 kb · p 0.75 · regional, not allelic |
| Overall | ||
| CADD | 0.028 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.551% | 181 |
| Middle Eastern | 0.0166% | 6,012 |
| Admixed American | 0.00544% | 18,395 |
| Remaining individualsnot grpmax-eligible | 0.00163% | 61,280 |
| European (non-Finnish) | 0.00086% | 116,227 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CEP162
- Protein
- p.Met77Thr
- Coding
- c.230T>C
- MANE Select
- NM_014895
- Type
- single nucleotide variant
- Location
- chr6:84215865 (GRCh38)
- Gene constraint
- LOEUF 1.101 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 63.93
Similar variants
- CEP162 p.Met77Ile Likely benign ★ same residue
- CEP162 p.Leu1052Pro Uncertain significance ★★ ⚠ same type
- CEP162 c.687+3A>G Uncertain significance ★ same type
- CEP162 p.Ala1224Val Uncertain significance ★ ⚠ same type
- CEP162 p.Ala1359Gly Uncertain significance ★ ⚠ same type
- CEP162 p.Ala190Thr Uncertain significance ★ ⚠ same type
- CEP162 p.Ala375Asp Uncertain significance ★ ⚠ same type
- CEP162 p.Ala494Thr Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cep162-p-met77thr (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown